SIFI > About
Vision & History

Established in 1935 by two local pharmacists in Sicily, SIFI started as a venture, specializing in the preparation of ophthalmic products. Since then, research, development, innovation and production have never stopped. Today, SIFI has evolved into an industrial group of companies, consolidating domestic leadership and expanding into international markets worldwide.

A closer look …
SIFI, the leading Italian ophthalmic company, has been focused on Eye Care since its foundation in 1935, featuring an integrated business model, from research & development to manufacturing and commercialization both in the pharmaceutical and biomedical sectors.

Our mission is to improve people’s lives through meaningful  innovation in eye care.

SIFI provides ophthalmologists and their patients with a wide range of therapeutic solutions, including  innovative pharmaceuticals, medical devices and nutraceuticals.

SIFI concentrates its R&D and manufacturing in Italy and exports towards more than 20 countries with a direct presence in Italy, Spain, France, Romania, Mexico and Turkey.

Since June 2015, SIFI is backed by 21 Invest, a private equity firm founded by Alessandro Benetton, to support the company’s expansion strategy, which is based on establishing (or acquiring) direct commercial operations in major European markets and expanding its network of international distributors.


share & tag us with
#history #EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
Quality We CARE for patients; all patients, even those frequently left behind by the industry, such as individuals afflicted by rare diseases.   SIFI’s 80-year long history is distinguished...
 
Vision & History Established in 1935 by two local pharmacists in Sicily, SIFI started as a venture, specializing in the preparation of ophthalmic products. Since then, research, development,...
 
Disclosure of Transfers of value    SIFI is a pharmaceutical company committed to fulfilling the needs of its customers, both patients and ophthalmologists.   SIFI strongly...

On our Social Channels

From our News Center

SIFI, the main Italian ophthalmic pharmaceutical company, is actively involved in the fight against COVID-19, and is alongside physicians, nurses and health personnel, to help face together the...
 

 

23 October

Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, and SIFI S.p.A. (“SIFI”), a prominent Italian...
Follow Us!